AMO recall continues
This article was originally published in The Tan Sheet
Executive Summary
FDA announces Aug. 1 many consumers may not be aware of Advanced Medical Optics Complete MoisturePlus Multipurpose Contacts Lens Solution recall first issued in May. The firm first announced its recall in May due to a potential link between the solution and Acanthamoeba keratitis, a rare eye infection, in soft contact lens wearers (1"The Tan Sheet" June 4, 2007, In Brief). FDA says several cases of the disease have been reported to the Centers for Disease Control and Prevention after the recall was announced...
You may also be interested in...
AMO’s mixed first quarter
Advance Medical Optics' overall eye care sales are flat at $59 million (a 0.5 percent increase) during the firm's fiscal 2008 first quarter, according to a May 1 release. A 24.6 percent drop in multi-purpose solution sales, "reflecting recall-related impacts" (1"The Tan Sheet" Aug. 26, 2007, In Brief), cancelled out a 37 percent increase in other eye care sales, including the U.S. launch of Blink Tears, AMO's first OTC dry eye product, the firm says. Nonetheless, AMO's net sales rose 20.7 percent to $303.7 million during the first quarter - affirming the firm's 2008 expectations for revenues between $1.22 billion to $1.24 billion, according to the release...
AMO recalls Complete MoisturePlus
Advanced Medical Optics recalls the multipurpose contact lens solution after the Centers for Disease Control and Prevention reports a potential link between the product and Acanthamoeba keratitis, a rare eye infection, the Santa Ana, Calif.-based firm announces May 25. AMO says it voluntary initiated a worldwide recall out of "an abundance of caution" in response to reports 46 people had developed AK, 21 of whom used Complete MositurePlus the month prior to symptom onset. AMO adds the current recall is unrelated to reports of the fungal infection Fusarium keratitis that led to Bausch & Lomb's worldwide recall of its ReNu with MoistureLoc contact lens solution in 2006 1("The Tan Sheet," April 17, 2006, p. 5)...
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.